Andrew McGovern

Mr. Andrew McGovern

Biological Sciences, University of Limerick, Limerick, Ireland
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
GBGeorge E. Barreto
George E. Barreto
AMAndrew McGovern
Andrew McGovern
LGLuis Miguel Garcia-Segura
Luis Miguel Garcia-Segura
Estradiol exerts neuroprotective actions that are mediated by the regulation of a variety of signaling pathways and homeostatic molecules. Among these is neuroglobin, which is upregulated by estradiol and translocated to the mitochondria to sustain neuronal and glial cell adaptation to injury. In this paper, we will discuss the role of neuroglobin in the neuroprotective mechanisms elicited by estradiol acting on neurons, astrocytes and microglia. We will also consider the role of neuroglobin in the neuroprotective actions of clinically relevant synthetic steroids, such as tibolone. Finally, the possible contribution of the estrogenic regulation of neuroglobin to the generation of sex differences in brain pathology and the potential application of neuroglobin as therapy against neurological diseases will be examined.

Verified
Journal Article
Open access
PDF file
AMAndrew McGovern
Andrew McGovern
M.-A. ArevaloM.-A. Arevalo
M.-A. Arevalo
SCSergio Ciordia
Sergio Ciordia
LGLuis Miguel Garcia-Segura
Luis Miguel Garcia-Segura
GBGeorge E. Barreto
George E. Barreto
The existence of sex differences in disease incidence is attributed, in part, to sex differences in metabolism. Uncovering the precise mechanism driving these differences is an extraordinarily complex process influenced by genetics, endogenous hormones, sex-specific lifetime events, individual differences and external environmental/social factors. In fact, such differences may be subtle, but across a life span, increase susceptibility to a pathology. Whilst research persists in the hope of discovering an elegant biological mechanism to underpin sex differences in disease, here, we show, for the first time, that such a mechanism may be subtle in nature but influenced by multiple sex-specific factors. A proteomic dataset was generated from a gonadectomized mouse model treated with Tibolone, a menopausal hormone therapy. Following functional enrichment analysis, we identified that Alzheimer’s disease and the electron transport chain-associated pathways were regulated by sex-hormone interactions. Specifically, we identified that the expression of three respirasome proteins, NDUFA2, NDUFA7 and UQCR10, is significantly altered by compounding factors that contribute to sex differences. These proteins function in bioenergetics and produce reactive oxygen species, which are each dysregulated in many diseases with sex differences in incidence. We show sex-specific reprogrammed responses to Tibolone following gonadectomy, which primarily influence the expression of proteins contributing to metabolic pathways. This further infers that metabolic differences may underpin the observed sex differences in disease, but also that hormone therapy research now has potential in exploring sex-specific interventions to produce an effective method of prevention or treatment.
1

25 March 2022 in International Immunopharmacology
Verified
Journal Article
Open access
AMAndrew McGovern
Andrew McGovern
JGJanneth González
Janneth González
David RamirezDavid Ramirez
David Ramirez
GBGeorge E. Barreto
George E. Barreto
Traumatic Brain Injury (TBI) has long-term devastating effects for which there is no accurate and effective treatment for inflammation and chronic oxidative stress. As a disease that affects multiple signalling pathways, the search for a drug with a broader spectrum of pharmacological action is of clinical interest. The fact that endocrine disruption (e.g hypogonadism) has been observed in TBI patients suggests that endogenous therapy with testosterone, or its more androgenic derivative, dihydrotestosterone (DHT), may attenuate, at least in part, the TBI-induced inflammation, but the underlying molecular mechanisms by which this occurs are still not completely clear. In this study, the main aim was to investigate proteins that may be related to the pathophysiological mechanism of TBI and also be pharmacological targets of DHT in order to explore a possible therapy with this androgen using network pharmacology. We identified 2.700 proteins related to TBI and 1.567 that are potentially molecular targets of DHT. Functional enrichment analysis showed that steroid (p-value: 2.1-22), lipid metabolism (p-value: 2.8-21) and apoptotic processes (p-value: 5.2-21) are mainly altered in TBI. Furthermore, being mitochondrion an organelle involved on these molecular processes we next identified that out of 32 mitochondrial-related proteins 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), peroxisome proliferator activated receptor gamma (PPGARG) and prohibitin are those found highly regulated in the network and potential targets of DHT in TBI. In conclusion, the identification of these cellular nodes may prove to be essential as targets of DHT for therapy against post-TBI inflammation.

24 October 2025 in Psychoneuroendocrinology
Verified
Journal Article
Open access
BLBonnie H. Lee
Bonnie H. Lee
AMAndrew McGovern
Andrew McGovern
SLStephanie E. Lieblich
Stephanie E. Lieblich
SMSelene V. Mitchell
Selene V. Mitchell
JYJie Yin
Jie Yin
LGLiisa A.M. Galea
Liisa A.M. Galea
Cognitive aging is influenced by sex and sex-specific factors. Indeed, research has shown that parity (pregnancy and parenthood) uniquely alters biomarkers of brain health in middle age depending on Alzheimer's disease (AD) risk. This study investigated functional connectivity changes and network dynamics at middle age based on parity and APOEε4 genotype, the top genetic risk factor for late-onset sporadic AD risk. Neural activation was assessed in middle-aged wildtype and hAPOEε4 rats that were either nulliparous (0 litters) or primiparous (1 litter), by quantifying expression of the immediate early gene, zif268, across 19 brain regions implicated in memory and AD. Primiparous hAPOEε4 rats exhibited widespread reductions in neural activation, particularly in the dorsal striatum, nucleus accumbens, frontal cortex, and retrosplenial cortex. Network analyses further revealed that primiparous wildtype rats had the most cohesive and efficient functional connectivity networks. Activation of hippocampal new neurons in conjunction with the dorsal striatum, frontal cortex, and retrosplenial cortex dynamically predicted cognitive performance depending on parity and hAPOEε4 genotype. These findings underscore the importance of considering sex-specific factors in aging and AD research.

1 October 2026 in Science
Verified
Journal Article
Closed access
LGLaura L. Gravelsins
Laura L. Gravelsins
MPMateja Perović
Mateja Perović
MAMadeline Wood Alexander
Madeline Wood Alexander
TSTallinn F. L. Splinter
Tallinn F. L. Splinter
AMAndrew McGovern
Andrew McGovern
LGLiisa A. M. Galea
Liisa A. M. Galea
Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increasing, research on strategies for menopause symptom management and optimizing health in the postmenopausal period is lacking. This Review highlights that menopause characteristics, such as type, timing, and symptom burden, influence health outcomes and later-life disease risk. Similarly, menopause hormone therapy comes in >200 varieties that differ by dose, formulation of estrogens and progestogens, and timing, each with their own distinct risk-benefit profiles. These distinctions are often missed in the literature but have considerable repercussions for outcomes. Optimized menopause care necessitates a precision medicine approach that considers menopause symptoms, genetics, and previous hormone exposures.